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Angiogenesis induced by vascular endothelial growth factor (VEGF) plays an important role in psoriasis.
Hypoxic adaptation is conferred through hypoxia-inducible transcription factors (HIFs). VEGF and its receptor
Flt-1 are HIF target genes. Growth factors and inflammatory cytokines activate the phosphoinositol-3 kinase
pathway, and via activated protein kinase B (phospho-Akt) augment HIF activity. Here, we demonstrate that the
major oxygen-dependent HIF isoforms are strongly upregulated in psoriatic skin: HIF-1a mainly in the
epidermis, in an expression pattern similar to VEGF mRNA; HIF-2a in both the epidermis and in capillary
endothelial cells of the dermis. In contrast, normal human skin shows low expression of HIF-a proteins, with the
exception of hair follicles, and glands, which strongly express HIF-1a. In normal human skin, phospho-Akt
appeared in the basal epidermal layer, in hair follicles, and in dermal glands. In contrast, in psoriasis, phospho-
Akt expression was low in the epidermis, but markedly enhanced in the dermal capillaries and in surrounding
interstitial/inflammatory cells. Our data suggest that hypoxia initiates a potentially self-perpetuating cycle
involving HIF, VEGF, and Akt activation, which could drive physiologic growth of hair follicles and skin glands.
Furthermore, such a cycle may exist in psoriasis in dermal capillaries and contribute to disease progression.
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INTRODUCTION
Psoriasis is a genetically determined chronic inflammatory
skin disorder, which is triggered by environmental stimuli.
There is increasing evidence that both innate and adaptive
immunity are involved, but neither have potential self-
antigens been isolated, nor has the specificity of autoreactive
skin-infiltrating lymphocytes been defined (reviewed by
Bachelez, 2005; Scho¨n and Boehncke, 2005; Gaspari,
2006; Griffiths et al., 2006).
Angiogenesis is a hallmark of psoriasis. Microvessels of the
papillary dermis are elongated, tortuous, dilated, and show
increased endothelial cell proliferation. Pivotal angiogenic
genes like vascular endothelial growth factor (VEGF) and its
receptors are upregulated (Detmar et al., 1994). Several lines
of evidence suggest that VEGF upregulation is an early and
important step in the pathophysiology of psoriasis (reviewed
by Detmar, 2004). In mice, chronic transgenic delivery of
VEGF to the skin induces inflammation and all the
characteristics of psoriasis suggesting a causative role of
VEGF in this disease (Xia et al., 2003). Using a potent VEGF
antagonist, the VEGF-Trap, reverses this phenotype (Xia et al.,
2003). Distinct genetic polymorphisms leading to increased
circulating VEGF in healthy humans have been shown
to associate with psoriasis (Young et al., 2004). Thus,
an ‘‘angiogenic constitution’’ might determine psoriasis
susceptibility.
Transcriptional activation of VEGF and of its receptor Flt-1
can be achieved by so-called hypoxia-inducible factors (HIFs)
(Liu et al., 1995; Gerber et al., 1997). In contrast, the VEGF
receptor kinase insert domain receptor (KDR) seems not to be
regulated by HIFs (Gerber et al., 1997). HIFs are heterodimers
of a constitutive b-subunit and one of at least two different
a-subunits (reviewed by Wenger, 2002; Maxwell, 2004;
Metzen and Ratcliffe, 2004; Semenza, 2004). Regulation of
the HIF system occurs by oxygen-dependent hydrolysis of
HIF-a. HIF transcription factors are ubiquitously expressed,
instantaneously upregulated upon hypoxia, short-lived upon
reoxygenation, and confer cell/tissue protection through
many HIF target genes (reviewed by Wenger, 2002;
Rosenberger et al., 2005b). The key enzymes of HIF-a
proteolysis, so-called HIF prolyl hydroxylases function in
the range of physiologic/pathologic oxygen tensions (Epstein
et al., 2001), thus fulfilling conditions required for true
oxygen sensors. Using high-amplification immunohistochem-
istry, HIF-1a and -2a have been demonstrated in various rat
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and human tissues (Wiesener et al., 2002, 2003; Rosenberger
et al., 2002, 2003, 2005, 2006; Warnecke et al., 2003;
Ju¨rgensen et al., 2004; Bernhardt et al., 2006; Goldfarb et al.,
2006). Normal tissues were constantly HIF negative, but
several hypoxic maneuvers showed that the two isoforms,
HIF-1a and -2a, are activated in a cell-type- and stimulus-
specific pattern (Rosenberger et al., 2002, 2003, 2005, 2006;
Ju¨rgensen et al., 2004; Goldfarb et al., 2006). Comparison
with the hypoxia marker pimonidazole (which binds to
tissues at oxygen tensions below 10 mm Hg (Franko and
Chapmann, 1982) demonstrated that HIF activation occurs in
areas which stain positive for pimonidazole, but cells are
unable to accumulate HIF in the most severely hypoxic
structures (Rosenberger et al., 2005, 2006).
In psoriasis, cell proliferation could increase oxygen
consumption, and epidermal thickening could lead to
impaired oxygen supply. The aim of this study was to test
the hypothesis that intensified hypoxia and consequent HIF
activation is involved in psoriatic skin angiogenesis.
RESULTS
Expression of HIF-a in normal human skin
In normal human skin (Figure 1), HIF-1a protein expression
was low and focal in the epidermis (Figure 1d). But, hair
follicles (Figure 1a), sebaceous glands (Figure 1b), and sweat
glands (Figure 1c) abundantly expressed HIF-1a. In addition,
HIF-2a protein was rarely detectable, mostly in the dermis
(Figure 1g).
Evidence for hypoxia and hypoxic adaptation in rat skin
In concordance with the data in normal human skin, normal
rat skin showed occasional epidermal HIF-1a immunostain-
ing and strong HIF-1a staining in hair follicles (Figure 2c). No
HIF-2a (Figure 2e) signals were detectable. The hypoxia
marker, pimonidazole, confirmed deep hypoxia of hair
follicles in normal skin (Figure 2a). To test the potential for
HIF activation, we induced systemic hypoxia by exposing rats
to 0.1% carbon monoxide (CO, functional anemia) or to 8%
ambient oxygen in a hypoxic chamber for 4 hours (Rosen-
berger et al., 2002). As expected, both maneuvers intensified
existing HIF-1a staining (shown for CO in Figure 2c). In
addition, some dermal interstitial/endothelial cells became
positive for HIF-1a (Figure 2c), as well as for HIF-2a protein
(Figure 2f). Pimonidazole adducts became detectable in the
basal epidermal layers, as well as in interstitial cells of the
dermis (Figure 2b). Interestingly, hypoxia markers were
induced to a similar extent by both CO and 8% O2 (data
not shown), suggesting that oxygen diffusion through the
stratum corneum was limited.
Upregulation of HIF-a in psoriasis
Psoriatic skin showed marked upregulation of HIF-1a
(Figure 1e) and -2a (Figure 1h) protein throughout the
epidermis. In addition, in the dermis, HIF-2a (Figure 1i) was
strongly activated, and some HIF-1a signals (Figure 1f)
appeared as well. High magnification revealed that most
HIF-1a and -2a signals located in capillary endothelial cells
of dermal papillae (Figure 1f and i, insets).
HIF-1a mRNA was increased in the epidermis of psoriatic
skin (Figure 3b).
Transcriptional upregulation of VEGF and its receptor
Flt-1 in psoriasis
As detected by in situ hybridization (ISH), mRNAs for both
VEGF and its receptor Flt-1 were increased in psoriatic skin,
as compared with normal human skin. These results confirm
previous data (Detmar et al., 1994). In accordance with VEGF
and Flt-1 being HIF target genes (Liu et al., 1995; Gerber
et al., 1997), VEGF mRNA and HIF-1a colocated in
keratinocytes of the epidermis (Figure 3e), whereas Flt-1
mRNA (Figure 3h) and both HIF-a isoforms appeared in
capillary endothelial cells of the dermis.
Expression of activated Akt (phospho-Akt) in normal skin
and in psoriasis
Phospho-Akt indicates activation of the phosphoinositol-3
kinase pathway, which can occur in response to growth
factors like VEGF (Kilic et al., 2006) and tumor necrosis
factor-a (Zhou et al., 2003), and was shown to activate HIF in
vivo (Semenza, 2000). To test whether phosphoinositol-3
kinase activation may account for the HIF-upregulation seen
in normal and psoriatic skin, additional phospho-Akt
immunostainings were performed. Indeed, in normal skin
phospho-Akt was detectable at the sites of maximum HIF-1a
immunosignals: in hair follicles (Figure 4c), in sebaceous
glands (Figure 4d) and in sweat glands (data not shown).
Furthermore, phospho-Akt abundantly appeared in the basal
epidermal layer (Figure 4a). Noteworthy, in normal rat or
human skin HIF-1a showed no clear predilection for the basal
epidermal layer (Figures 1d and 2c). In psoriasis, epidermal
phospho-Akt was reduced (Figure 4b), but intense signals
appeared in capillary endothelial cells of dermal papillae
(Figure 4b and inset therein), coincident with HIF-1a and -2a
(compare Figure 1f and i, insets). Additional phospho-Akt
located in and surrounding deeper dermal vessels (Figure 5b).
Parallel sections revealed strong perivascular phospho-Akt
signals in areas of infiltrating CD8 lymphocytes (Figure 5a),
suggesting that at least some CD8 lymphocytes activated Akt.
By contrast, on parallel sections no clear link between HIF-2a
and CD8 signals could be established (Figure 5c).
DISCUSSION
The main findings of this study are 3-fold: first, hypoxia and
hypoxia adaptation occur in normal skin, especially in hair
follicles and dermal glands (Figure 1a–c); second, HIFs are
strongly activated in psoriasis (Figure 1e, f, h, and i), in cell
types which express pivotal angiogenic factors (Figure 2e and
h); and third, Akt is activated in normal hair follicles and
dermal glands (Figure 4c and d), as well as in psoriatic dermal
vessels (Figure 4b).
Specificity of hypoxia detection through HIFs
The specificity of HIF-a protein for hypoxia has been
challenged, as hypoxia-unrelated factors like inflammatory
cytokines, growth factors, and reactive oxygen species have
been shown to induce HIF in cell cultures kept under 21%
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oxygen (Haddad and Harb, 2005; Hellwig-Burgel et al.,
2005; Maranchie and Zhan, 2005). However, the fact that in
normal rat skin HIF-1a protein colocates with pimonidazole
(Figure 2) strongly suggests hypoxia-dependent HIF stimula-
tion. Unfortunately, we were unable to use pimonidazole in
our human skin biopsies, and therefore cannot rule out that
factors other than hypoxia had (at least partly) been
responsible for HIF activation in psoriasis.
Hypoxia and hypoxia adaptation occur in normal skin
Several lines of evidence suggest that oxygen tensions are low
in normal skin. Distler et al. (2004) and Bedogni et al. (2005)
demonstrated nuclear HIF-1a in the epidermis of humans and
mice. Cobb et al. (1990) found accumulation of tritium-
labeled pimonidazole in sebaceous glands. Bedogni et al.
(2005) also showed accumulation of EF5 (a bioreductive
agent like pimonidazole) in the epidermis and hair follicles of
normal mice. This study confirms the presence of regional
hypoxia and HIF activation in normal skin (Figure 2a and c)
and extends previous findings by showing a strong activation
of HIF-1a in hair follicles and dermal glands (Figure 1a–c).
Noteworthy, in rat skin HIFa immunosignals were enhanced
to a similar extent by both CO admixture to room air and




Figure 1. Expression of HIF-1a and -2a protein in normal human skin and in psoriasis. (a–c) HIF-1a in normal human skin: (a) hair follicles, (b) sebaceous
glands, (c) sweat glands, (d) epidermis; HIF-2a in normal human skin: (g) psoriasis: HIF-1a (e) epidermis, (f) dermis, inset with higher magnification);
HIF-2a (h) epidermis, (i) dermis, inset with higher magnification). Arrowheads point to endothelial cells. In normal skin, HIF-1a is strongly expressed in
(a) hair follicles, (b) sebaceous glands, and (c) sweat glands. (d) By contrast, nuclear HIF-1a staining only rarely occurs in normal epidermis. (g) Nuclear
HIF-2a signals occasionally occur in normal dermis. Psoriasis exhibits (e) strong upregulation of HIF-1a in the epidermis and (f) to a lesser extent in the dermis.
In addition, HIF-2a is upregulated (h) in the epidermis and (h and i) in the dermis. Bars¼ (a–e, g, h) 600 mm; (f and i) 150 mm; insets in (f and i) 50mm.
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oxygen supply was critical to the skin. Moreover, to our
knowledge this is the first report of Akt activation in normal
hair follicles and dermal glands (Figure 4c and d). As
reviewed by Detmar (2000), the vasculature of adult skin
remains normally quiescent due to the dominant influence of
endogenous angiogenesis inhibitors over angiogenic stimuli.
But, skin retains the capacity for brisk initiation of angiogen-
esis. Cyclic vascular expansion due to keratinocyte-derived
VEGF occurs in the growth phase of hair follicles. VEGF can
augment HIFa mRNA translation into protein via phospho-
inositol-3 kinase and Akt (Semenza, 2000; Kilic et al., 2006).
To our knowledge, there is no evidence for Akt activation by
hypoxia per se. Possibly, within the physiologic cycle of hair
follicles and dermal glands hypoxia activates HIF, HIF
activates VEGF, VEGF activates Akt, and Akt augments HIF-
response, thus forming a positive feedback loop.
HIF and Akt are activated in psoriasis
This is the first report of HIF activation in psoriasis. HIFs
regulate both VEGF (Liu et al., 1995) and its receptor
Flt-1 (Gerber et al., 1997), which play a pivotal role in
psoriatic angiogenesis (reviewed by Detmar, 2004). We
show that HIFa colocates with VEGF in the epidermis. In
addition, we demonstrate that in psoriasis HIFa, Flt-1,
and activated Akt all occur in dermal capillaries (insets in
Figures 1f, i, and 4b).
HIF expression is pronounced in perivascular areas where
one would expect the least hypoxia. However, as oxygen
level is a balance between supply and consumption, in these
perivascular areas oxygen consumption (e.g., by inflamma-
tory cells, stromal cells, endothelial cells, etc.) might exceed
oxygen supply, thus leading to relative hypoxia.
Several lines of evidence suggest a crucial role for
augmented VEGF response and the so-called ‘‘angiogenesis
predisposition’’ in the pathophysiology of psoriasis (reviewed
by Detmar, 2004). However, it remains unclear, whether
such predisposition also includes alterations upstream of the
VEGF gene, such as the HIF system.
Noteworthy, mice with transgenic cutaneous VEGF
upregulation are the only animal models capable of
reproducing the complete psoriatic phenotype (Xia et al.,
2003). In these mice, psoriatic plaques evolve spontaneously
after a period of approximately 6 months, which is prevented
by VEGF inhibition (Xia et al., 2003). By contrast, short-time
delivery of VEGF to the skin does not produce psoriatic
lesions (Sundberg et al., 2001). Such data suggest that
long-term cutaneous VEGF activation is necessary and
sufficient to induce psoriasis. By contrast, inflammatory
cytokines (like tumor necrosis factor-a) or keratinocyte
growth factors (like transforming growth factor-a) alone do
not induce the complete psoriatic phenotype, as demon-
strated by various transgenic mouse models (reviewed by
Xia et al., 2003).
These data offer a first hint that HIFs and Akt could be
important players in psoriatic angiogenesis, which theoreti-
cally would fit into the existing plot of inflammation and
epithelial proliferation.
Additionally, T lymphocytes play an important role in the
pathophysiology of psoriasis. Interestingly, T lymphocytes
from psoriasis patients induce typical psoriatic plaques in
xenografts of uninvolved psoriatic skin, but not in xenografts
of normal skin, as shown in the severe combined immune
deficiency mouse model (reviewed by Scho¨n and Boehncke,




Figure 2. Immunohistochemical evidence for hypoxia in rat skin. Left panels:
controls; right panels: hypoxia (0.1% CO); (a and b) pimonidazole;
(c and d) HIF-1a; (e and f) HIF-2a. Arrows point to the epidermis;
arrowheads¼ interstitial/endothelial cells; open arrows¼hair follicles.
(a) In normal rat skin, pimonidazole adducts prove deep hypoxia in hair
follicles. (c) HIF-1a protein appears in hair follicles, and occasionally in the
epidermis, (e) but staining for HIF-2a is negative. After 4 hours of functional
anemia (0.1% CO in hypoxic chamber) hypoxia is intensified.
(b) Pimonidazole adducts appear de novo in interstitial cells of the dermis,
and in the epidermal layer. (d) HIF-1a signals are more abundant in the
epidermis, and some interstitial signals appear in the dermis, as well. (f) In
addition, some interstitial/endothelial cells of the dermis stain positive for
HIF-2a. Bar¼240 mm.
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to psoriatic pathophysiology, given that HIF is involved in
T-cell survival and function (Kojima et al. 2003; Makino
et al., 2003; Nakamura et al. 2005).
Nevertheless, our data suggest that, at least in established
psoriatic plaques, most CD8 lymphocytes are HIF-negative,
as perivascular CD8 lymphocytes expressed phospho-Akt but
not HIFa. However, as immunostaining for HIF and CD8
were incompatible in terms of antigen retrieval, we were only
able make a rather rough estimate based on parallel sections.
Moreover, we cannot exclude HIF activation in T cells at
earlier stages of psoriasis.
Conclusion
Physiologic regional hypoxia occurs in dermal glands and
hair follicles, possibly initiating a cycle involving HIF, VEGF,
and Akt activation, which has the potential for self-perpetua-
tion. Most likely, skin hypoxia is further intensified in
psoriasis, where keratinocyte and endothelial HIF could
promote angiogenesis by differentially upregulating VEGF
and its receptor Flt-1, respectively. Moreover, in dermal
capillaries, phospho-Akt likely provides a positive feedback
to the HIF/VEGF system.
MATERIALS AND METHODS
The study was conducted according to the Declaration of Helsinki
Principles.
Human tissue
Biopsies of involved skin from 10 patients with psoriasis and of
unremarkable skin from five control patients were obtained after
written informed consent. Institutional approval was not necessary
for the human studies, as all biopsies were diagnostic. Biopsies were
fixed for 1 hour in freshly depolimerized 3% paraformaldehyde (in
phosphate-buffered saline, pH 7.4) at 41C, after which they were
transferred into ice-cooled phosphate-buffered saline, and em-
bedded into paraffin within 2–6 hours. Additional 10 archival
biopsies from psoriatic patients and three frozen biopsies from




Figure 3. ISH for HIF-1a, VEGF, and its receptor Flt-1 in normal and psoriatic human skin. Left panels: normal skin, antisense probes; mid panels:
psoriasis, antisense probes; right panels: psoriasis, sense probes. (a–c) HIF-1a; (d–f) VEGF; (g–i) Flt-1. Staining with (a, d, g) antisense probes in normal skin is
not different from staining with sense probes (exemplified for psoriasis in c, f, i), which is consistent with background activity. On the contrary, all three
antisense probes show more abundant signals in psoriasis: HIF-1a and VEGF in the epidermis, and Flt-1 in endothelial cells of dermal vessels. Bar¼150 mm.
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Animal studies
The study was approved by the Institutional Review Board for the
care of animal subjects, and was performed in accordance with
National Institute of Health guidelines. Six male Sprague–Dawley
rats (Winkelmann, Borchem, Germany) were used at weights of
200–280 g. For the induction of hypoxia (functional anemia), animals
were placed in an air-tight Plexiglas cabinet, and exposed for 4 hours
to normal air with 0.1% CO, or to a mixture of 8% O2 and 92% N2
(Rosenberger et al., 2002). For the detection of pimonidazole
adducts as markers of tissue hypoxia, pimonidazole (Hypoxyprobe,
Natural Pharmacia International, Belmont, MA) was delivered
intravenously at 60 mg/kg at 1 hour before euthanasia (Rosenberger
et al., 2003). In the case of hypoxic induction, animals were briefly
taken out of the hypoxic chamber in order to receive their
pimonidazole injection. Tissue were fixed and embedded into
paraffin, as detailed above.
Immunohistochemistry
Staining with mouse-anti-human HIF-1a (which cross-reacts with
rat HIF-1a; a67, Novus Biologicals, Littleton, CO; 1:10,000),
rabbit-anti-rat HIF-2a (PM9, gift from Patrick Maxwell, Oxford,
UK; 1:10,000), rabbit-anti-human HIF-2a (190b, gift from Patrick
Maxwell, Oxford, UK; 1:1,000), and mouse-anti-pimonidazole
(Hypoxyprobe, Natural Pharmacia International, Belmont, MA;
1:1,000) was performed as described previously (Rosenberger
et al. 2002, 2003). Staining for phospho-Akt (Ser-473) was performed
with a rabbit polyclonal antibody (1:1,000) from Cell Signaling
Technology (Beverly, MA; cat. no. 3787, immunohistochemistry
specific) after antigen retrieval (25 minutes boiling in 0.01 M citrate
buffer, pH 6.0). Staining for CD8 was performed on formalin-fixed
cryostate sections using mouse-anti-human CD8 (clone CLB-T8/4,
4H8, PeliCluster, Amsterdam, The Netherlands; 1:1,000).
ISH
ISH was performed on 5mm paraffin sections. Details of ISH have
been published previously (Brown et al., 1992). Briefly, slides were
a b
c d
Figure 4. Expression of activated Akt (phospho-Akt) in normal and
psoriatic human skin. Control skin: (a, c) hair follicles, (d) sebaceous glands;
(b) psoriasis. Arrows point to the epithelium; arrowheads¼ interstitial/endothelial
cells. Inset in panel a is a high-power magnification of the outlined area. In
normal skin, phospho-Akt is detectable in the basal layer of (a) the epidermis,
(c) in hair follicles, and (d) in sebaceous glands. In psoriasis, epidermal
phospho-Akt is rarer, but intense dermal signals appear (b and high power




Figure 5. Perivascular CD8 lymphocytes in psoriasis. Six micrometers
parallel cryostate sections. (a) CD8, (b) phospho-Akt, (c) HIF-2a. Signals
appear brown; blue counter staining with hematoxylin. Arrowheads indicate
corresponding capillaries. Owing to antigen retrieval (pressure cooker), tissue
is altered in (b) and (c). (a) CD8 lymphocytes appear in clusters surrounding
dermal vessels. (b) Phospho-Akt signals locate in endothelial cells and in the
surroundings of vessels, in areas of CD8 positivity, suggesting that at least
some CD8 lymphocytes had activated Akt. (c) By contrast, nuclear HIF-2a
signals were rare in this area, and mostly located in endothelial cells. Our
data suggest that CD8 lymphocytes did not activate HIF. Bar¼270 mm.
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passed through xylene, graded alcohols, 0.2 M HCl; Tris/EDTA with
3mg/ml proteinase K; 0.2% glycine; 4% paraformaldehyde in
phosphate-buffered saline, pH 7.4; 0.1 M triethanolamine containing
1/200 (vol/vol) acetic anhydride; and 2 standard saline citrate
(SSC). Slides were hybridized overnight at 501C with 35S-labeled
riboprobes in the following mixture: 0.3 M NaCl, 0.01 M Tris, pH 7.6,
5 mM EDTA, 50% formamide, 10% dextran sulfate, 0.1 mg/ml yeast
tRNA, and 0.01 M dithiothreitol. Post-hybridization washes included
2 SSC/50% formamide/10 mM dithiothreitol at 501C; 4 SSC/
10 mM Tris/1 mM EDTA with 20 mg/ml ribonuclease A at 371C; and
2 SSC/50% formamide/10 mM dithiothreitol at 651C and 2 SSC.
Slides were then dehydrated through graded alcohols containing
0.3 M ammonium acetate, dried, coated with Kodak NTB 2 emulsion,
and stored in the dark at 41C for 2 weeks. The emulsion was
developed with Kodak D19 developer and the slides were counter-
stained with hematoxylin. Antisense 204 bp single-stranded 35S-
labeled VEGF-A RNA probe and its sense have been described
previously (Brown et al., 1992). The antisense probe hybridizes
specifically with a region of VPF/VEGF mRNA common to all known
VPF/VEGF splicing variants. 35S-labeled single-stranded 225 bp
antisense probe targeted to the kinase insert region and sense RNA
probes for the VEGF-A receptor VEGFR-1 (vascular endothelial
growth factor receptor-1, Flt-1) have been described previously
(Brown et al., 1993). Probes for HIF-1a (246 bp) were obtained from
737–983 bp of the cDNA, with both sense and antisense orientation
confirmed by sequencing.
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